On April 21st, we received exciting news from the Shanghai Municipal Commission of Science and Technology. They announced the inclusion of ConFlow MedTech in the "2023 Second Batch of Technology-Based SMEs." This achievement follows our recent recognition as an Innovative Small and Medium Enterprise in Shanghai, marking another significant milestone for ConFlow MedTech.
Technology-based SMEs are defined as enterprises that leverage scientific and technological expertise to engage in R&D activities. It requires businesses to acquire independent intellectual property rights and convert them into high-tech products or services, aiming to achieve sustainable growth. SME represents the most dynamic, potential-rich, and innovation-driven group within the business landscape.
Being classified as a technology-focused SME is a significant endorsement of our innovation prowess. Such recognition grants us access to valuable benefits, including national financial subsidies and tax exemptions. Moreover, we receive widespread support and guidance in areas such as technology project applications, high-tech enterprise development, financial services, and other aspects.
ConFlow MedTech remains committed to advancing progress through technology, fostering growth via innovation, and facilitating the clinical application of cutting-edge medical advancements. At current stage, we are actively pursuing specialized, refined, distinctive, and innovative high-tech enterprise recognition. We are confident that our unwavering efforts will further strengthen our company's capabilities and technological innovation.
-
September 17,2021Celebrating its one-year milestone, ConFlow MedTech successfully concluded its first-anniversary event, joined by supporters and partners.
-
July 24,2023Good News | ConFlow MedTech was awarded as "Specialized and Sophisticated SME" in Shanghai City
-
September 18,2023Thank you for being with us as we celebrate the third anniversary of ConFlow MedTech's establishment!
Pursue further excellence!
